Diagnosing liver fibrosis in hepatitis B patients in Africa: can we use low-cost biomarkers?
Low-cost biomarkers using routinely available blood tests are used to make treatment decisions for patients with hepatitis B. How well do these work in Africa, where over 80 million people are living with chronic infection?
